MAPS:NASDAQWM Technology, Inc. Analysis
Data as of 2026-05-19 - not real-time
$0.38
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading well below its short‑term and long‑term moving averages, with momentum indicators showing a mid‑range relative strength index and a bullish MACD crossover despite a decreasing volume trend. The discounted cash‑flow model suggests a fair value far above the current price, implying a massive upside potential, and the market sentiment index is in the extreme greed zone, indicating strong investor enthusiasm. Technical patterns point to a potential short‑term rebound, while the broader bearish trend remains a concern.
Recent material news confirms the company’s transition to a regulated OTC market and the release of a profitable first‑quarter earnings report, highlighting cash generation and a modest net income. However, revenue growth remains negative, operating margins are thin, and the business operates in a highly regulated cannabis software niche, which adds regulatory risk. The balance sheet shows ample cash relative to debt, and forward earnings multiples are dramatically lower than trailing multiples, reinforcing the undervalued narrative. Overall, the combination of a deep discount to intrinsic value, improving earnings, and sector‑specific challenges creates a nuanced investment picture.
Recent material news confirms the company’s transition to a regulated OTC market and the release of a profitable first‑quarter earnings report, highlighting cash generation and a modest net income. However, revenue growth remains negative, operating margins are thin, and the business operates in a highly regulated cannabis software niche, which adds regulatory risk. The balance sheet shows ample cash relative to debt, and forward earnings multiples are dramatically lower than trailing multiples, reinforcing the undervalued narrative. Overall, the combination of a deep discount to intrinsic value, improving earnings, and sector‑specific challenges creates a nuanced investment picture.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near support with bearish trend
- decreasing volume indicating limited short‑term buying pressure
- bullish MACD suggesting possible near‑term bounce
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- significant upside to intrinsic value
- improving earnings and cash flow
- transition to a regulated OTC platform enhancing credibility
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- deep discount to discounted cash‑flow estimate
- low forward earnings multiple relative to peers
- sustained demand for cannabis compliance software despite regulatory headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth-2.40%
Profit Margin0.86%
P/E Ratio37.9
ROE1.91%
ROA4.67%
Debt/Equity19.01
P/B Ratio0.7
Op. Cash Flow$19.2M
Free Cash Flow$13.0M
Industry P/E38.2
Technical Analysis
TrendBearish
RSI42.9
Support$0.31
Resistance$0.44
MA 20$0.37
MA 50$0.50
MA 200$0.85
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61
Valuation
Fair Value$1.16
Target Price$2.61
Upside/Downside588.47%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.50
Volatility190.75%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.